Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: Prognostic significance

Journal of Thoracic and Cardiovascular Surgery

Volumn 114, Issue 3, 1997, Pages 339-346

  Dobashi, K ^a   Sugio, K ^a   Osaki, T ^a   Oka, T ^a   Yasumoto, K ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030761048     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(97)70178-8     Document Type: Article

References (18)

1. N Martini M Bains R Ginsberg Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
2. M Trojani I Mascarel G Delsol F Bonichon JM Coindre G. Delsol Micrometastasis to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance Br J Cancer 55 1987 303 306
3. N Hayashi I Ito Y Nakamura Genetic diagnosis of lymph-node metastasis in colorectal cancer Lancet 345 1995 1257 1259
4. ZL Chen S Perez AJ Cochran Frequency and distribution of occult micrometastasis in lymph nodes of patients with non-small-cell lung carcinoma J Natl Cancer Inst 85 1993 45 49
5. B Passlick JR Izbicki B Kubuschok O Thetter K. Pantel Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis Ann Thorac Surg 61 1996 177 183
6. C Betz T Papadopoulos J Buchwald J Dammrich HK. Muller-Hermelink Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: detection by reverse transcriptase-polymerase chain reaction Cancer Res 55 1995 4283 4286
7. A Casson N Kerkvliet F. O'Malley Prognostic value of p53 protein in esophageal adenocarcinoma J Surg Oncol 60 1995 5 11
8. Y Maehara M Yamamoto K Sugimachi Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer Br J Cancer 73 1996 83 87
9. S Thorban J Roger H Nekarda A Funk J Siewert K. Pantel Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma J Natl Cancer Inst 17 1996 1222 1227
10. K Pantel J Izbicki B Passlick Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small-cell lung cancer without overt metastases Lancet 347 1996 649 653
11. CC Harris M. Hollstein Clinical implications of the p53 tumor-suppressor gene N Engl J Med 329 1993 1318 1327
12. T Soussi Y Legros R Lubin K Ory B. Schlichtholz Multifactorial analysis of p53 alteration in human cancer: a review Int J Cancer 57 1994 1 9
13. Y Kishimoto Y Murakami M Shiraishi K Hayashi T. Sekiya Aberration of the p53 tumor suppressor gene in human non-small cell carcinoma of the lung Cancer Res 52 1992 4799 4804
14. T Mitsudomi SM Steinberg AF Gazdar p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features Oncogene 7 1992 171 180
15. S Benchimol D Pim L. Crawford Radioimmunoassay of the cellular protein p53 in mouse and human cell lines EMBO J 7 1982 1055 1062
16. E Brambilla S Gazzeri C Brambilla Immunohisto-chemical study of p53 in human lung carcinomas Am J Pathol 143 1993 199 210
17. G Fontanini D Bigini F Squartini p53 expression in non small cell lung cancer: clinical and biological correlations Anticancer Res 13 1993 737 742
18. T Mitsudomi T Oyama K Yasumoto p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival Ann Oncol 6 1995 9 13